In unadjusted analyses, there was a stepwise increase in the rates of each of the primary composite outcome, HF hospitalization, CV death, and all‐cause death across the no diabetes (reference group), non‐insulin‐treated diabetes, and insulin‐treated diabetes groups. This evidence concerns the gene INS and diabetes mellitus.